tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Schmidt, 42 are a BUY (100%).
Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 50.43% that have a potential upside of 43.03% achieved within 672 days. Previously, Eric Schmidt worked at TD COWEN.
Eric Schmidt’s has documented 80 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LEGN, Legend Biotech Corp at 17-Dec-2025.
Analyst best performing recommendations are on ALMS (ALUMIS COMMON STOCK).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 17-Mar-2026
$175
$-42.15 (-19.41%)
$150
Buy Since 15-May-2026
$245
$27.85 (12.83%)
$225
13 days ago
(03-Sep-2026)
4/9 (44.44%)
$20.49 (9.13%)
54
Buy Since 04-Mar-2022
$260
$42.85 (19.73%)
$240
22 days ago
(25-Aug-2026)
51/85 (60%)
$39.23 (17.77%)
158
Buy Since 28-Sep-2022
$241
$23.85 (10.98%)
$221
1 months 12 days ago
(04-Aug-2026)
25/41 (60.98%)
$32.55 (15.62%)
152
Hold Since 15-Jun-2021
$215
$-2.15 (-0.99%)
$200
1 months 13 days ago
(03-Aug-2026)
28/37 (75.68%)
$13.18 (6.53%)
215
What Year was the first public recommendation made by Eric Schmidt?
